Ocular Advisory Board
Jeffrey Heier, M.D.
Background: Jeffrey Heier, M.D., is Assistant Professor, Tufts University School of Medicine, and Clinical Instructor, Harvard Medical School. He is also a vitreoretinal specialist for Ophthalmic Consultants of Boston. Dr. Heier was one of the lead investigators of Genentech's MARINA and FOCUS studies and has served as an advisor or consultant to Genentech, Eyetech Pharmaceuticals, Pfizer, VisionCare Ophthalmic Technologies, OXiGENE, Jerini, Novartis, iScience Surgical Corp., Genzyme, and Carl Zeiss Meditec. Surgery Branch. Prior to joining the Yale University School of Medicine, he was Vice President for Clinical Affairs at Vion Pharmaceuticals.
Jason Slakter, M.D.
Background: Jason Slakter, M.D., is a board-certified vitreoretinal surgeon and macular-disease specialist and currently practices at the Vitreous-Retina-Macula Consultants in New York City. In addition, he is a Clinical Professor of Ophthalmology at NYU's School of Medicine and an attending surgeon and Surgeon Director at the Manhattan Eye, Ear, and Throat Hospital in New York. Dr. Slakter is an internationally recognized retinal specialist whose chief research interests relate to exudative AMD, retinal vascular disease, and central serous chorioretinopathy. He serves on the medical advisory boards of many biotechs and pharmaceutical companies involved in these areas. Dr. Slakter is Editor-in-Chief of Retinal Physician and is on the editorial board of Retina.